Bloomberg Technology

Developing Antibodies for Covid-19

Sep.28 — Jennifer Bath, chief executive officer at Immunoprecise Antibodies Ltd., discusses the company’s potentially groundbreaking Covid-19 antibody treatment on “Bloomberg Technology.”

Published

on

Sep.28 — Jennifer Bath, chief executive officer at Immunoprecise Antibodies Ltd., discusses the company’s potentially groundbreaking Covid-19 antibody treatment on “Bloomberg Technology.”

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version